The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Clorox Co

NYSE: CLX
Last

(U.S.) $124.38

Today's change-0.33 -0.26%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.
 

Clorox Co

NYSE: CLX
Last

(U.S.) $124.38

Today's change-0.33 -0.26%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

Clorox Co down (U.S.)$0.33

Clorox Co closed lower Friday, dropping (U.S.)$0.33 or 0.26% to (U.S.)$124.38. Shares have lost 3.62% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P 500 by 23.96% during the last year.

Key company metrics

  • Open(U.S.) $124.95
  • Previous close(U.S.) $124.71
  • High(U.S.) $125.81
  • Low(U.S.) $122.40
  • Bid / Ask-- / --
  • YTD % change-1.93%
  • Volume1,733,193
  • Average volume (10-day)1,603,616
  • Average volume (1-month)1,261,845
  • Average volume (3-month)1,094,125
  • 52-week range(U.S.) $103.77 to (U.S.) $132.19
  • Beta0.38
  • Trailing P/E25.01×
  • P/E 1 year forward25.33×
  • Forward PEG3.45×
  • Indicated annual dividend(U.S.) $3.08
  • Dividend yield2.48%
  • Trailing EPS(U.S.) $4.97
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.54%

Based on its net profit margin of 11.54%, Clorox Co is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.08%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Household Products
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue1,3451,3901,5571,401
Total other revenue--------
Total revenue1,3451,3901,5571,401
Gross profit600625710605
Total cost of revenue745765847796
Total operating expense1,1151,1261,2681,184
Selling / general / administrative317309372330
Research & development34303934
Depreciation / amortization--------
Interest expense (income), net operating22232325
Unusual expense (income)--------
Other operating expenses, total-3-1-13-1
Operating income230264289217
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax230264289217
Income after tax151173189144
Income tax, total799110073
Net income149172191174
Total adjustments to net income--------
Net income before extra. items151173189144
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items151173189144
Inc. avail. to common incl. extra. items149172191174
Diluted net income149172191174
Dilution adjustment--------
Diluted weighted average shares132131132134
Diluted EPS excluding extraordinary itemsvalue per share1.151.321.431.07
Dividends per sharevalue per share0.770.770.770.74
Diluted normalized EPSvalue per share1.151.321.431.07